1. The ubiquitin-mediated proteolytic pathway as a therapeutic area

   • Mark Rolfe
   • M. Isabel Chiu
   • M. Pagano

   REVIEW Pages: 5 - 17

2. Inhibition of MHC class I antigen presentation by viral proteins

   • K. Früh
   • K. Ahn
   • P. A. Peterson

   REVIEW Pages: 18 - 27

3. Kaposi’s sarcoma: is the hunt for the culprit over now?

   • O. Schatz
   • Johannes R. Bogner
   • F.-D. Goebel

   REVIEW Pages: 28 - 34

4. Protein kinase mediators of integrin signal transduction

   • G. E. Hannigan
   • Shoukat Dedhar

   REVIEW Pages: 35 - 44

5. Telomerase activation and cancer

   • Aloysius J. Klingelhutz

   REVIEW Pages: 45 - 49

6. Germline p53 mutation at codon 133 in a cancer-prone family

   • Y. Saeki
   • Kazuo Tamura
   • Joji Utsunomiya

   ORIGINAL ARTICLE Pages: 50 - 56

7. Relationship of polymorphisms in the renin-angiotensin system and in E-selectin of patients with early severe coronary heart disease

   • K. Wenzel
   • A. Blackburn
   • A. Speer

   ORIGINAL ARTICLE Pages: 57 - 61

8. Investigation of the Met-267 Arg exchange in isoform 1 of the human plasma membrane calcium pump in patients with essential hypertension by the amplification-created restriction site technique

   • C. Benkwitz
   • C. Kubisch
   • L. Neyses

   ORIGINAL ARTICLE Pages: 62 - 66

9. Cancer risk and oxidative DNA damage in man

   • S. Loft
   • H. E. Poulsen

   REVIEW Pages: 67 - 68

10. Decreased methylene tetrahydrofolate reductase activity due to the 677C→T mutation in families with spina bifida offspring

    • N. M. J. van der Put
    • R. P. M. Steegers-Theunissen
    • H. J. Blom

    ORIGINAL ARTICLE Pages: 69 - 69